Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 17;14(1):24365.
doi: 10.1038/s41598-024-74035-x.

Differentiating neurodegenerative diseases based on EEG complexity

Affiliations

Differentiating neurodegenerative diseases based on EEG complexity

Giovanni Mostile et al. Sci Rep. .

Abstract

Neurodegenerative diseases are common causes of impaired mobility and cognition in the elderly. Among them, tauopathies and α-synucleinopathies were considered. The neurodegenerative processes and relative differential diagnosis were addressed through a qEEG non-linear analytic method. Study aims were to test accuracy of the power law exponent β applied to EEG in differentiating neurodegenerative diseases and to explore differences in neuronal connectivity among different neurodegenerative processes based on β. N = 230 patients with a diagnosis of tauopathy or α-synucleinopathy and at least one artifact-free EEG recording were selected. Periodogram was applied to EEG signal epochs from continuous recordings. Power law exponent β was determined by the slope of the signal power spectrum versus frequency in logarithmic scale. A data-driven clustering based on β values was performed to identify independent subgroups. Data-driven clustering based on β differentiated tauopathies (overall lower β values) from α-synucleinopathies (higher β values) with high sensitivity and specificity. Tauopathies also presented lower values in the correlation coefficients matrix among frontal sites of recording. In conclusion, significant differences in β values were found between tauopathies and α-synucleinopathies. Hence, β is proposed as a possible biomarker of differential diagnosis and neuronal connectivity.

Keywords: Degenerative diseases; Quantitative EEG; Spectrum power-law decay exponent; Tauopathies; α-Synucleinopathies.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Non-hierarchical clustering of neurodegeneration based on EEG power-law exponent β. (N = 230; 2 Groups by pseudo-F). LEFT: Cluster A: N = 77. RIGHT: Cluster B: N = 153. Cluster A presented overall sig. higher β values, including more α-synucleinopathies with impaired cognition (PDMCI, PDD). Cluster B presented overall sig. lower β values, including more tauopathies with impaired cognition (PSP, CBD, AD).
Fig. 2
Fig. 2
Topoplot showing differences in topographical distribution of power-law exponent β based on selected sites of recordings between Cluster A and Cluster B as well as in principal included α-synucleinopathies (for Cluster A) and tauopathies (for Cluster B). Range colours based on β values from lower (blue) to higher (yellow).
Fig. 3
Fig. 3
Heatmap of correlation coefficients matrix showing differences in functional connectivity among frontal sites of recording between identified clusters (LEFT: Cluster A, N = 77; RIGHT: Cluster B, N = 153) based on β values. Range colours based on correlation r.

References

    1. Dugger, B. N. & Dickson, D. W. Pathology of neurodegenerative diseases. Cold Spring Harb. Perspect. Biol. 9, a028035 (2017). - PMC - PubMed
    1. Erkkinen, M. G., Kim, M. O. & Geschwind, M. D. Clinical neurology and epidemiology of the major neurodegenerative diseases. Cold Spring Harb. Perspect. Biol. 10, a033118 (2018). - PMC - PubMed
    1. Henderson, M. X., Trojanowski, J. Q. & Lee, V. M. α-Synuclein pathology in Parkinson’s disease and related α-synucleinopathies. Neurosci. Lett. 709, 134316 (2019). - PMC - PubMed
    1. Donoghue, T. et al. Parameterizing neural power spectra into periodic and aperiodic components. Nat. Neurosci. 23, 1655–1665 (2020). - PMC - PubMed
    1. McMackin, R. et al. Measuring network disruption in neurodegenerative diseases: new approaches using signal analysis. J. Neurol. Neurosurg. Psychiatry 90, 1011–1020 (2019). - PMC - PubMed

LinkOut - more resources